Glycemic Control in Diabetic Hospitalized Patients

Glycemic Control in Diabetic Hospitalized Patients: a Cross Sectional Study

With the advanced management of diabetes and new innovative anti-hyperglycemic therapy hyperglycemia remains a culprit factor affecting the outcome of patients admitted to the hospital in general wards. Efforts from health care providers to assess and control blood sugar by a simplified method such as certified point of care hand-sized glucometers is the fruitful protocol if the results near the target that is endorsed by well-known diabetes societies. In non-critically patients the premeal blood sugar ≤140 mg /dl and ≤ 180 mg /dl after a meal. The unstable economy and political crises with the pandemic of Covid-19 making us use a glucometer to monitor and control the fluctuation of blood sugar in order to decrease the burden on the patients and health care providers in the form of a stay in the hospital and minimize wasting laboratory resources.

Study Overview

• Status: Completed
• Conditions: Diabetes Mellitus; Diabetes

• Study Type: Observational
• Enrollment (Actual): 120

Contacts and Locations

• Study Contact: Name: Alhasan M Al-Mudhaffer, BCPS; Phone Number: +9647801601693; Email: user11126@gmail.com

Study Locations

• Iraq
  • Basra, Iraq, 99999
    • AlFayhaa Teaching hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

diabetic patients admitted in the hospital

Description

Inclusion Criteria:

• admitted to the hospital

Exclusion Criteria:

• none

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
glycemic control	percentage of patients with glucose measurement (Random Blood Sugar, RBS, Fasting Blood Sugar, FBS) between 140-180 measured with bedside glucometers preferably before meals and at 6 am for fasting blood sugars or as directed by the physician	From hospital admission to hospital discharge for a median of 7 days and up to 1 month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
average blood glucose value per ward	average blood glucose value per ward (medical vs. surgical vs ICU/CCU	From hospital admission to hospital discharge for a median of 7 days and up to 1 month
average per patient	average blood glucose levels per patient	From hospital admission to hospital discharge for a median of 7 days and up to 1 month

Collaborators and Investigators

• Sponsor: AlFayhaa General Hospital
• Investigators: Study Chair: AbdulSattar J Yousif, MD, Al-Fayhaa teaching hospital; Study Chair: Ali Hussein A Alhamza, MD, Al-Fayhaa teaching hospital

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2021
• Primary Completion (Actual): July 1, 2021
• Study Completion (Actual): July 1, 2021

Study Registration Dates

• First Submitted: March 5, 2021
• First Submitted That Met QC Criteria: March 14, 2021
• First Posted (Actual): March 16, 2021

Study Record Updates

• Last Update Posted (Actual): December 27, 2022
• Last Update Submitted That Met QC Criteria: December 23, 2022
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Keywords: hyperglycemia; diabetes mellitus; glycemic control; inpatient
• Additional Relevant MeSH Terms: Glucose Metabolism Disorders; Metabolic Diseases; Endocrine System Diseases; Diabetes Mellitus
• Other Study ID Numbers: 1121

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided
• IPD Plan Description: unidentified patient data will be shared if requested

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No